Companies › BCAX

BICARA THERAPEUTICS INC (BCAX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0002023658 · EDGAR filings · Updated 2026-07-28

BICARA THERAPEUTICS INC (BCAX) has reported institutional ownership of 108.9%, with 147 institutional managers holding positions valued at $1.40B per the latest 13F reporting period.

Filings this week (2)

• 2026-07-28 — Current report (8-K) filed
• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-14 — Insider transaction reported (Form 4)
• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-07-10 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BICARA THERAPEUTICS INC has 147 institutional holders and institutional ownership of 108.9%.

Insider activity

Insiders reported 95 transactions (1 buys, 50 sells) across 6 reporting insiders, with a net reported value of −$3.89M.

Related companies

BELITE BIO INC (BLTE) · INTELLIA THERAPEUTICS INC (NTLA) · Procept Biorobotics Corp (PRCT) · KALVISTA PHARMACEUTICALS INC (KALV) · PROGYNY INC (PGNY) · IMMUNITYBIO INC (IBRX)